CPRXEUR: Catalyst Pharmaceuticals Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
398 institutions reported holding $3.22B of Catalyst Pharmaceuticals Inc on Form 13F (384 the quarter before). 96 opened a new position and 82 sold out. Shares held by institutions: +3%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 19,158,785 | $602.16M |
| STATE STREET CORP | 7,627,036 | $239.72M |
| AMERICAN CENTURY COMPANIES INC | 5,553,921 | $174.56M |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,135,345 | $161.40M |
| DIMENSIONAL FUND ADVISORS LP | 3,634,171 | $114.22M |
| JPMORGAN CHASE & CO | 3,169,902 | $99.89M |
| GEODE CAPITAL MANAGEMENT, LLC | 3,150,256 | $99.03M |
| HBK INVESTMENTS L P | 2,820,302 | $88.64M |
| MORGAN STANLEY | 2,760,358 | $86.76M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,428,922 | $76.34M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.